KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zoetis (ZTS) Research & Development (2016 - 2026)

Zoetis has reported Research & Development over the past 12 years, most recently at $199.0 million for Q4 2025.

  • Quarterly Research & Development rose 6.99% to $199.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $698.0 million through Dec 2025, up 1.75% year-over-year, with the annual reading at $698.0 million for FY2025, 1.75% up from the prior year.
  • Research & Development was $199.0 million for Q4 2025 at Zoetis, up from $170.0 million in the prior quarter.
  • Over five years, Research & Development peaked at $199.0 million in Q4 2025 and troughed at $118.0 million in Q1 2021.
  • The 5-year median for Research & Development is $150.0 million (2022), against an average of $152.2 million.
  • Year-over-year, Research & Development grew 17.86% in 2021 and then decreased 3.09% in 2025.
  • A 5-year view of Research & Development shows it stood at $138.0 million in 2021, then rose by 7.25% to $148.0 million in 2022, then grew by 17.57% to $174.0 million in 2023, then grew by 6.9% to $186.0 million in 2024, then rose by 6.99% to $199.0 million in 2025.
  • Per Business Quant, the three most recent readings for ZTS's Research & Development are $199.0 million (Q4 2025), $170.0 million (Q3 2025), and $172.0 million (Q2 2025).